Black Diamond Therapeutics
BDTX
BDTX
87 hedge funds and large institutions have $103M invested in Black Diamond Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $212M → $103M (-$109M)
77% less call options, than puts
Call options by funds: $38K | Put options by funds: $165K
Holders
87
Holding in Top 10
–
Calls
$38K
Puts
$165K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$1.39M | |
| 3 | +$1.22M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$1.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$868K |
Top Sellers
| 1 | -$3.8M | |
| 2 | -$3.06M | |
| 3 | -$3.03M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$2.58M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.41M |